Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL.
McComb S, Aguade-Gorgorio J, Harder L, Marovca B, Cario G, Eckert C, Schrappe M, Stanulla M, von Stackelberg A, Bourquin JP, Bornhauser BC
Sci Transl Med. 2016 May 18;8(339):339ra70. doi: 10.1126/scitranslmed.aad2986.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
75159pLentiCRISPR-EGFPDerived from LentiCRISPR v1 but expresses EGFP instead of puromycin resistance
75160pLentiCRISPR-tagBFPDerived from LentiCRISPR v1 but expresses tagBFP instead of puromycin resistance
75161pLentiCRISPR-mCherryDerived from LentiCRISPR v1 but expresses mCherry instead of puromycin resistance. 3rd generation.
75162pLentiCRISPR-RFP657Derived from LentiCRISPR v1 but expresses RFP657 instead of puromycin resistance
75163pLC-EGFP-RIP1LentiCRISPR-EGFP with sgRNA targeting human RIPk1
75164pLC-RFP657-CASP8LentiCRISPR-RFP657 with sgRNA targeting human Caspase-8
75165pLC-EGFP-RIP3LentiCRISPR-EGFP with sgRNA targeting human RIP3
75166pLC-BFP-FADDLentiCRISPR-BFP with sgRNA targeting human FADD
75167pLC-mCherry-MLKLLentiCRISPR-mCherry with sgRNA targeting human MLKL

Antibodies from Article